Mehedi v. View, Inc. f/k/a CF Finance Acquisition Corp. II

Opinion

1 2 3 UNITED STATES DISTRICT COURT 4 NORTHERN DISTRICT OF CALIFORNIA 5 SAN JOSE DIVISION 6 7 ASIF MEHEDI, et al., Case No. 21-cv-06374-BLF

8 Plaintiffs, ORDER GRANTING MOTION TO 9 v. ALTER OR AMEND THE JUDGMENT AND FOR RELIEF FROM A FINAL 10 VIEW, INC., et al., JUDGMENT, ORDER, OR PROCEEDING AND VACATING 11 Defendants. JUDGMENT

12 [Re: ECF No. 203]

13 14 Before the Court is Lead Plaintiff Stadium Capital LLC and named Plaintiff David 15 Sherman’s motion to alter or amend the judgment under Federal Rule of Civil Procedure 59(e) and 16 for relief from a final judgment, order, or proceeding under Federal Rule of Civil Procedure 60(b). 17 ECF No. 203 (“Mot.”). Defendants other than View, Inc.1 filed an opposition to the motion. ECF 18 No. 208 (“Opp.”). Plaintiffs filed a reply. ECF No. 211 (“Reply”). The Court took the motion 19 under submission without oral argument. ECF No. 207; Civ. L.R. 7-1(b). 20 For the reasons below, the Court GRANTS the motion and VACATES the judgment. 21 I. BACKGROUND 22 The background of this case is laid out in detail in the Court’s Order granting the motion to 23 dismiss Plaintiffs’ second amended complaint. ECF No. 200 (“MTD SAC”). The Court will 24 provide an abbreviated version here. 25 This is a putative class action for securities fraud against View, Inc. and various 26 individuals connected to View’s SEC filings. Plaintiffs allege that, in various public filings from 27 1 November 20, 2020 to May 17, 2021, Defendants made material misrepresentations to investors 2 concerning a materially misstated and understated warranty accrual related to View’s “smart 3 panels.” See, e.g., ECF No. 175 (“SAC”) ¶¶ 87, 92. 4 On August 18, 2021, the initial complaint was filed in this case. See ECF No. 1 5 (“Compl.”). On February 8, 2022, the Court appointed Stadium Capital LLC as Lead Plaintiff. 6 ECF No. 67. On July 15, 2022, Stadium Capital filed the first amended complaint. See ECF No. 7 96 (“FAC”). On May 2, 2023, the Court granted Defendants’ motions to dismiss and dismissed all 8 of Stadium Capital’s claims with leave to amend. See ECF No. 168. On August 21, 2023, 9 Stadium Capital filed the second amended complaint. See SAC. In addition to narrowing the 10 claims to a Section 14(a) claim, a Section 10(b) claim, and their Section 20(a) counterparts, the 11 second amended complaint changed the end of the class period from May 10, 2022 to November 12 9, 2021 and sought to add an additional Named Plaintiff: David Sherman. SAC ¶¶ 26–44. 13 On April 9, 2024, the Court granted Defendants’ motions to dismiss without leave to 14 amend. See MTD SAC at 19–20. The Court found that, because Stadium Capital sold its shares 15 before the truth of the underlying falsehood was revealed, Stadium Capital was not injured by the 16 alleged misrepresentations and thus lacked standing to pursue any of its claims. Id. at 10–16. 17 Because the Court found that Stadium Capital did not have and never had standing to pursue its 18 claims, the addition of David Sherman was not permitted under established law. See id. at 16–19. 19 II. LEGAL STANDARD 20 Under Federal Rule of Civil Procedure 59(e), a party may file a motion to alter or amend 21 judgment within 28 days after entry of the judgment. See Fed. R. Civ. P. 59(e). The Ninth Circuit 22 has identified “four basic grounds upon which a Rule 59(e) motion may be granted: (1) if such 23 motion is necessary to correct manifest errors of law or fact upon which the judgment rests; (2) if 24 such motion is necessary to present newly discovered or previously unavailable evidence; (3) if 25 such motion is necessary to prevent manifest injustice; or (4) if the amendment is justified by an 26 intervening change in controlling law.” Allstate Ins. Co. v. Herron, 634 F.3d 1101, 1111 (9th Cir. 27 2011). 1 rule offers an extraordinary remedy, to be used sparingly in the interests of finality and 2 conservation of judicial resources.” Kona Enters., Inc. v. Est. of Bishop, 229 F.3d 877, 890 (9th 3 Cir. 2000) (internal quotation marks and citation omitted). Rule 59(e) relief “should not be 4 granted, absent highly unusual circumstances, unless the district court is presented with newly 5 discovered evidence, committed clear error, or if there is an intervening change in the controlling 6 law.” 389 Orange St. Partners v. Arnold, 179 F.3d 656, 665 (9th Cir. 1999). “A Rule 59(e) 7 motion may not be used to raise arguments or present evidence for the first time when they could 8 reasonably have been raised earlier in the litigation.” See Kona, 229 F.3d at 890 (emphasis in 9 original). 10 Under Federal Rule of Civil Procedure 60(b), the Court may relieve a party from a final 11 judgment, order, or proceeding for the following reasons:

12 (1) mistake, inadvertence, surprise, or excusable neglect; (2) newly discovered evidence that, with reasonable diligence, could not have 13 been discovered in time to move for a new trial under Rule 59(b); (3) fraud (whether previously called intrinsic or extrinsic), 14 misrepresentation, or misconduct by an opposing party; (4) the judgment is void; (5) the judgment has been satisfied, released, or 15 discharged; it is based on an earlier judgment that has been reversed or vacated; or applying it prospectively is no longer equitable; or 16 (6) any other reason that justifies relief.

17 Fed. R. Civ. P. 60(b). Mere dissatisfaction with the Court’s order, or belief that the Court is 18 wrong in its decision, are not grounds for relief under Rule 60(b). Twentieth Century-Fox Film 19 Corp. v. Dunnahoo, 637 F.2d 1338, 1341 (9th Cir. 1981); Beckway v. DeShong, No. C07-5072 20 TEH, 2012 WL 1355744, at *2 (N.D. Cal. Apr. 18, 2012). 21 III. DISCUSSION 22 Plaintiffs argue that the Court’s finding that Stadium Capital did not have standing was 23 “clear error” under Fed. R. Civ. P. 59(e) or “mistake [or] inadvertence” under Fed. R. Civ. P. 24 60(b) because the Court conflated constitutional standing with statutory standing. Mot. at 1. 25 More precisely, Plaintiffs argue that a failure to plead loss causation is an issue of statutory 26 standing and, because Stadium Capital has constitutional standing, the addition of Sherman as a 27 named plaintiff is appropriate. Mot. at 4–12. Defendants respond that Plaintiffs’ motion is 1 procedurally improper because Plaintiffs failed to raise their standing arguments in their 2 opposition to the motion to dismiss. Opp. at 2–3. Defendants also argue that the order dismissing 3 the second amended complaint was correct and that Plaintiffs mischaracterized the law. Id. at 3– 4 11. 5 A. Whether Plaintiffs’ Motion Is Procedurally Improper 6 Defendants argue that Plaintiffs’ motion is procedurally improper because it raises new 7 arguments for the first time that could have reasonably been raised in Plaintiffs’ opposition to the 8 motions to dismiss. Opp. at 2–3. Plaintiffs respond that Defendants’ arguments were related to 9 loss causation and that Defendants never argued that the August 2021 disclosure was not “fairly 10 traceable” to the alleged misstatements. Reply at 15. 11 “Reconsideration motions may not be used to raise new arguments or introduce new 12 evidence if, with reasonable diligence, the arguments and evidence could have been presented 13 during consideration of the original ruling.” Berman v. Freedom Fin. Network, LLC, 30 F.4th 14 849, 859 (9th Cir. 2022). To the extent that Defendants raised issues with standing, Defendants’ 15 arguments were directed at loss causation and Defendant discussed standing in the last two 16 paragraphs of View’s motion to dismiss, in a section arguing that David Sherman cannot be added 17 as a named plaintiff. See ECF No. 13. In considering the ambiguity in how the issue was raised 18 and the fact that Plaintiffs were tasked with responding to three separate motions to dismiss raising 19 a significant number of issues, a party exercising reasonable diligence may not have been 20 sufficiently on notice that View’s loss causation arguments were directed at Stadium Capital’s 21 standing to raise it to the Court in the opposition. Accordingly, the Court will consider Plaintiffs’ 22 motion on the merits. 23 B. Whether the Order Dismissing the Second Amended Complaint Conflated Constitutional Standing and a Merits Inquiry 24 Plaintiffs first argue that the standing inquiry under Fed. R. Civ. P. 12(b)(1) is distinct from 25 a statutory standing inquiry under Fed. R. Civ. P. 12(b)(6). Mot. at 4. Next, Plaintiffs argue that 26 loss causation is a merits inquiry that requires only dismissal for failure to state a claim rather than 27 a lack of standing. Mot. at 6–7. Defendants respond that Plaintiffs mischaracterize the relevant 1 standard for assessing Article III standing at the pleading stage. Opp. at 4–5. Defendants also 2 argue that many courts have held that a shareholder that fails to allege loss causation fails to meet 3 the injury-in-fact and causation requirements for Article III standing. Id. at 6–8. Finally, 4 Defendants argue that Plaintiffs’ reliance on MacPhee v. MiMedx Grp., Inc., 73 F.4th 1220 (11th 5 Cir. 2023), is misplaced because the Eleventh Circuit’s analysis of the causation prong of Article 6 III standing is inconsistent with the Ninth Circuit’s standard. Id. at 8–9. 7 “To establish standing under Article III of the Constitution, a plaintiff must demonstrate 8 (1) that he or she suffered an injury in fact that is concrete, particularized, and actual or imminent, 9 (2) that the injury was caused by the defendant, and (3) that the injury would likely be redressed 10 by the requested judicial relief.” Thole v. U. S. Bank N.A, 590 U.S. 538, 540 (2020) (citing Lujan 11 v. Defenders of Wildlife, 504 U.S. 555, 560–61 (1992)). “To establish injury in fact, a plaintiff 12 must show that he or she suffered ‘an invasion of a legally protected interest’ that is ‘concrete and 13 particularized’ and ‘actual or imminent, not conjectural or hypothetical.’” Spokeo, Inc. v. Robins, 14 578 U.S. 330, 339 (2016), as revised (May 24, 2016) (quoting Lujan, 504 U.S. at 560). The 15 second element requires the plaintiff to “demonstrat[e] that her injury-in-fact is . . . fairly traceable 16 to the challenged action.” Daniel v. Nat’l Park Serv., 891 F.3d 762, 767 (9th Cir. 2018) (quoting 17 Davidson v. Kimberly-Clark Corp., 889 F.3d 956, 967 (9th Cir. 2018)). 18 As an initial matter, the Court observes that Plaintiffs’ invocation of statutory standing in 19 this context is inaccurate. A “statutory” or “prudential” standing inquiry asks “whether the statute 20 grants the plaintiff the cause of action that he asserts. In answering that question, we presume that 21 a statute ordinarily provides a cause of action ‘only to plaintiffs whose interests fall within the 22 zone of interests protected by the law invoked.’” Bank of Am. Corp. v. City of Miami, Fla., 581 23 U.S. 189, 196–97 (2017) (quoting Lexmark Int’l, Inc. v. Static Control Components, Inc., 572 U.S. 24 118, 127 (2014)). Analysis of a plaintiff’s statutory standing requires a court to “determine, using 25 traditional tools of statutory interpretation” whether a plaintiff “falls within the class of plaintiffs 26 whom Congress has authorized to sue [under a particular statute].” Lexmark, 572 U.S. at 127–28. 27 A failure to plead statutory standing “shows a failure to state a claim, not a failure to establish 1 did not challenge, nor did the Court determine, whether Stadium Capital is a plaintiff authorized to 2 sue under the Securities Exchange Act. In arguing that loss causation should not be considered in 3 analyzing Article III standing, Plaintiffs appear to have conflated a merits inquiry with a statutory 4 standing inquiry. Although statutory standing is a merits inquiry, not every merits inquiry is a 5 question of statutory standing. Plaintiffs have not pointed the Court to any authority that treats 6 loss causation for Sections 10(b) and 14(a) claims as a question of statutory standing. In fact, the 7 few cases that the Court could find discussing statutory standing and loss causation treat the two 8 as distinct issues. See, e.g., In re Barclays Liquidity Cross & High Frequency Trading Litig., 390 9 F.Supp.3d 432, 446 (S.D.N.Y. 2019); Zapien v. Washington Mut., Inc., No. 07CV385 DMS 10 (CAB), 2008 WL 11509010, at *2 (S.D. Cal. Jan. 17, 2008). It is more accurate to characterize 11 Plaintiffs’ position as arguing that loss causation is a merits inquiry that requires an analysis 12 distinct from that of Article III standing. See Opp. at 6–7 (discussing cases that distinguish 13 between Article III standing and loss causation as a merits inquiry, rather than a statutory standing 14 inquiry) (citing MacPhee, 73 F.4th at 1240; Am. Signature, Inc. v. Moody’s Invs. Servs., Inc., No. 15 10 CIV. 5095 (PGG), 2023 WL 6661054, at *4 (S.D.N.Y. Oct. 12, 2023)). Accordingly, the Court 16 must analyze whether Article III standing and loss causation require distinct analyses. 17 Plaintiffs distinguish Article III standing and loss causation in two ways. First, Plaintiffs’ 18 opening brief argues that the Twombly and Iqbal pleading standard applied in motions under Rule 19 12(b)(6) is inapplicable to a motion challenging Article III standing under Rule 12(b)(1). Mot. at 20 4 (citing Maya v. Centex Corp., 658 F.3d 1060, 1068 (9th Cir. 2011)). However, this position has 21 been expressly rejected by the Ninth Circuit. Defendants raised a facial challenge to Stadium 22 Capital’s standing, in which Defendants accepted as true Plaintiffs’ allegations but asserted that 23 they were insufficient to invoke federal jurisdiction. See Leite v. Crane Co., 749 F.3d 1117, 1121 24 (9th Cir. 2014) (distinguishing between a facial and factual challenge to jurisdictional allegations 25 in a complaint). The Ninth Circuit has held that “[t]he district court resolves a facial attack as it 26 would a motion to dismiss under Rule 12(b)(6).” Id.; see also TransUnion, 594 U.S. at 431 (“A 27 plaintiff must demonstrate standing ‘with the manner and degree of evidence required at the 1 has acknowledged that the portion of Maya v. Centex on which Plaintiffs rely is no longer good 2 law. See Jones v. L.A. Cent. Plaza LLC, 74 F.4th 1053, 1056 n.1 (9th Cir. 2023). It follows that 3 the Court did not err in applying the Twombly and Iqbal pleading standard in assessing whether 4 Stadium Capital has standing to pursue its Sections 10(b) and 14(a) claims. 5 Second, Plaintiffs refine their argument in their reply brief to state that loss causation is a 6 “separate and more demanding” standard than the “fairly traceable” element of Article III 7 standing. Reply at 3. On this ground, the Court agrees with Plaintiffs. Whether a plaintiff’s 8 injury is “fairly traceable” to the defendant’s conduct requires less than a showing of proximate 9 cause. See Bennett v. Spear, 520 U.S. 154, 168 (1997) (noting that proximate cause is not 10 equivalent to whether an injury is “fairly traceable” to the defendant); Maya, 658 F.3d at 1070 11 (noting that to establish causation for Article III standing, the plaintiff is not required to bear the 12 “heavy . . . burden” of demonstrating proximate cause); Canyon Cnty. v. Syngenta Seeds, Inc., 519 13 F.3d 969, 975 n.7 (9th Cir. 2008) (noting that, while the plaintiff could not show proximate cause, 14 the plaintiff adequately alleged causation for Article III standing); Williams v. Sisolak, No. 22- 15 16859, 2024 WL 194180, at *1 (9th Cir. Jan. 18, 2024) (“Although [Article III causation] does not 16 require a showing of proximate cause, it does require plaintiffs to establish a line of causation 17 between defendants’ action and their alleged harm that is more than attenuated.” (internal 18 quotation marks omitted) (quoting Maya¸658 F.3d at 1070)). The loss causation requirement of 19 the Securities Exchange Act “requires no more than the familiar test for proximate cause.” 20 Mineworkers’ Pension Scheme v. First Solar Inc., 881 F.3d 750, 753 (9th Cir. 2018); Lloyd v. 21 CVB Fin. Corp., 811 F.3d 1200, 1210 (9th Cir. 2016) (same); see also Dura Pharms., Inc. v. 22 Broudo, 544 U.S. 336, 346 (2005) (discussing loss causation as a question of proximate cause). It 23 follows that the loss causation elements of Sections 10(b) and 14(a) claims require a distinct and 24 more demanding analysis than that of the causation prong of Article III standing. 25 The Court pauses to observe that other courts have appropriately relied on the loss 26 causation analysis in Dura Pharmaceuticals to determine whether a plaintiff has Article III 27 standing to bring a claim. See, e.g., Brown v. Medtronic, Inc., 628 F.3d 451, 455 (8th Cir. 2010); 1 223, 237 (S.D.N.Y. 2012); In re Infineon Techs. AG Sec. Litig., 266 F.R.D. 386, 398 (N.D. Cal. 2 2009); In re Impax Lab’ys, Inc. Sec. Litig., No. C 04-04802 JW, 2008 WL 1766943, at *7 (N.D. 3 Cal. Apr. 17, 2008). It is not error to rely on Dura Pharmaceuticals to analyze Article III standing 4 because that case announced a rule of “pure logic” by which courts may evaluate fraud-on-the- 5 market theories of economic loss. Dura Pharms., 544 U.S. at 342. Under that rule, if a plaintiff 6 purchases shares at a price artificially inflated by a misrepresentation and sells those shares before 7 the relevant truth begins to leak out, then the plaintiff will not have suffered any loss as a result of 8 the misrepresentation because the plaintiff both purchased and sold the shares at the inflated rate. 9 Id. In such a situation, the fact that the plaintiff’s loss cannot be attributable to the alleged 10 misrepresentation is sufficient to show that the plaintiff’s injury is not fairly traceable to the 11 defendant’s conduct for Article III standing and to show that the plaintiff fails to adequately allege 12 loss causation and thus fails to state a claim. See Impax Lab’ys, 2008 WL 1766943, at *7 13 (applying Dura Pharmaceuticals in analyzing loss causation and standing); Bricklayers & Masons 14 Loc. Union No. 5 Ohio Pension Fund, 866 F.Supp.2d at 236 (same). However, as the Court 15 discusses in more detail in the following section, this case illustrates why loss causation and the 16 Article III standing analysis should be treated distinctly. This case includes factual allegations that 17 may establish an injury that is fairly traceable to Defendants’ conduct for Article III purposes but 18 are not sufficient to plead loss causation. See Brown, 628 F.3d at 457 (acknowledging that “[i]n 19 most cases . . . a plaintiff’s standing tracks his cause of action” but noting the importance of not 20 conflating standing with the plaintiff’s cause of action because “the concepts are not coextensive” 21 (quoting Braden v. Wal-Mart Stores, Inc., 588 F.3d 585, 591 (8th Cir. 2009))); MacPhee, 73 F.4th 22 at 1240 (“[W]hile a plaintiff may both lack standing and fail to state a claim, it is also true that a 23 plaintiff can meet the requirement for constitutional standing but nonetheless fail to state a 24 claim.”). 25 Accordingly, the Court finds that its prior order granting the motions to dismiss Plaintiffs’ 26 second amended complaint for lack of Article III standing clearly erred or was the product of 27 mistake or inadvertence because it analyzed only whether Plaintiffs had adequately alleged loss 1 causation but not whether Stadium Capital had Article III standing.2 2 C. Whether Stadium Capital Has Article III Standing 3 The Court next addresses whether Stadium Capital has Article III standing under the 4 appropriate “fairly traceable” standard. Plaintiffs argue that Stadium Capital has Article III 5 standing for Plaintiffs Section 10(b) claim because they have alleged that Stadium Capital held 6 View stock on August 16, 2021, the date that View announced that its Audit Committee began an 7 investigation into the adequacy of View’s previously disclosed warranty accrual, and that View’s 8 stock price fell the following day. See Reply at 6, 15. Plaintiffs also argue that Stadium Capital 9 has Article III standing for Plaintiffs’ Section 14(a) claim because they have alleged that Stadium 10 Capital held stock as of January 27, 2021, the record date on which it was entitled to vote on the 11 merger. See Mot. at 9–10. Defendants do not directly address these facts. 12 “To establish causation, plaintiffs must allege that their injuries are ‘fairly traceable’ to [the 13 defendant’s] conduct and ‘not the result of the independent action of some third party not before 14 the court.’ Plaintiffs must thus allege a ‘substantial probability’ that [the defendant] caused the 15 harm they claim to have suffered.” Winsor v. Sequoia Benefits & Ins. Servs., LLC, 62 F.4th 517, 16 525 (9th Cir. 2023) (first quoting Namisnak v. Uber Techs., Inc., 971 F.3d 1088, 1094 (9th Cir. 17 2020); then quoting City of Oakland v. Oakland Raiders, 20 F.4th 441, 452–53 (9th Cir. 2021)). 18 “A causation chain does not fail simply because it has several ‘links,’ provided those links are ‘not 19 hypothetical or tenuous’ and remain ‘plausib[le].’” Maya, 658 F.3d at 1070 (alteration in original) 20 (quoting Nat’l Audubon Soc., Inc. v. Davis, 307 F.3d 835, 849 (9th Cir.2002)). 21 The Court finds that the facts alleged in this case with respect to Stadium Capital, although 22 not sufficient to allege loss causation, are sufficient to demonstrate that Stadium Capital has 23 Article III standing to pursue its Sections 10(b) and 14(a) claims. The second amended complaint 24 alleges that Stadium Capital held 80,000 shares of CF II stock on January 27, 2021—the Record 25 Date on which holders of CF II class A common stock were entitled to vote on the proposed 26

27 2 Because the Court relies on binding Ninth Circuit and Supreme Court authority to reach this 1 merger between View and CF II. See SAC ¶ 1; ECF No. 175-2 (“SAC Ex. B”). Stadium Capital 2 sold its 80,000 shares on March 9, 2021, but it purchased more shares prior to August 16, 2021. 3 SAC Ex. B. On August 16, 2021, View announced that its Audit Committee “began an 4 independent investigation concerning the adequacy of the company’s previously disclosed 5 warranty accrual” and that View would not file its Form 10-Q for the second fiscal quarter of 6 2021. SAC ¶ 128. The following day, View’s stock price fell $1.26, or over 24%, to close at 7 $3.92. Id. Although Stadium Capital sold all of its shares on September 24, 2021—prior to the 8 November 9, 2021 announcement that View’s warranty accruals were materially misstated— 9 Stadium Capital held View stock as of the August 16, 2021 announcement. SAC Ex. B. 10 Accepting the facts in the second amended complaint as true, the Court finds that Plaintiffs have 11 adequately alleged that Stadium Capital suffered a loss and that the injury can be traced to the 12 announcement of the investigation on August 16, 2021. The Court finds Brown v. Medtronic 13 instructive. In Brown, the plaintiff alleged that in Fall 2007, shortly after the defendant issued a 14 product recall, stopped marketing the product, and instructed physicians to cease new uses of the 15 product, the stock price dropped. Brown, 628 F.3d at 454. The plaintiff sold his shares in May 16 and June 2008, prior to a more dramatic price drop in Fall 2008. Id. at 459. The Eighth Circuit, 17 emphasizing that it was not requiring the plaintiff to prove proximate cause, found that these 18 allegations were sufficient to establish an injury that is fairly traceable to the wrongful act. Id. 19 Consistent with Brown, Court holds that the facts above, when accepted as true and all reasonable 20 inferences are drawn in Plaintiffs’ favor, are sufficient to establish Article III standing because 21 they show that Stadium Capital suffered a loss and identify plausible links in a chain of causation 22 linking showing that Defendants’ wrongful conduct is at least a part of the cause of the injury. In 23 reaching this conclusion, the Court notes that it did not determine whether the August 16, 2021 24 disclosure is a corrective or partial corrective disclosure for loss causation and whether Stadium 25 Capital’s losses for shares it purchased after the January 27, 2021 Record Date were caused by 26 misrepresentations in the proxy. These are questions of proximate cause, and while answering 27 them in the negative would show that Stadium Capital cannot state a claim under Sections 10(b) 1 Article HI standing. 2 Because the Court finds that Stadium Capital has Article III standing to bring its Sections 3 10(b) and 14(a) claims, the Court also finds that Lierboe v. State Farm Mut. Auto. Ins. Co., 350 4 || F.3d 1018 (9th Cir. 2003) is inapplicable. Accordingly, the Court will issue an amended order 5 addressing the other arguments raised in Defendants’ motions to dismiss. 6 || IV. ORDER 7 For the foregoing reasons, IT IS HEREBY ORDERED that: 8 1. Plaintiff Stadium Capital LLC and named Plaintiff David Sherman’s motion to 9 alter or amend the judgment under Federal Rule of Civil Procedure 59(e) and for reconsideration 10 under Federal Rule of Civil Procedure 60(b) is GRANTED. 11 2. The Judgment at ECF No. 201 is hereby VACATED. 12 3. The Court will issue an Amended Order on Defendants’ motions to dismiss that 5 13 addresses the other arguments for dismissal. 14 15 || Dated: June 12, 2024

TH LABSON FREEMAN 17 United States District Judge 18 19 20 21 22 23 24 25 26 27 28